Fig. 2: Relative proportion of disease indications for HCT in Europe 2020.
a Relative proportion of allogeneic HCT. b Relative proportion of autologous HCT.
Fig. 2: Relative proportion of disease indications for HCT in Europe 2020. | Bone Marrow Transplantation
